Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
20.43
+0.61 (3.08%)
At close: May 15, 2026, 4:00 PM EDT
20.43
0.00 (0.00%)
Pre-market: May 18, 2026, 4:00 AM EDT
Sensei Biotherapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Sensei Biotherapeutics stock has a target of 50, which predicts a 144.74% increase from the current stock price of 20.43.
Price Target: $50 (+144.74%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 5, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Sensei Biotherapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $30 | Strong Buy | Maintains | $5 → $30 | +46.84% | Aug 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +389.48% | Jun 2, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $70 → $80 | Buy | Maintains | $70 → $80 | +291.58% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +291.58% | Mar 28, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.83
from -16.72
EPS Next Year
-8.26
from -2.83
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | n/a | n/a |
| Avg | n/a | n/a |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -2.91 | -3.96 |
| Avg | -2.83 | -8.26 |
| Low | -2.71 | -12.18 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.